SPORTS HEALTH
vol. 11 • no. 5
[ Editorial ]
T rust is a critically important component of the patient/ physician relationship. Patients can rarely assess medical issues with the knowledge that clinicians can, and they benefit most when an accurate assessment of their condition by their physician is directed toward optimal results. Understandably, developing mutual trust in the patient/physician relationship takes time but can be of tremendous benefit to the patient when faced with major consequential medical decisions.
In a medical crisis, few factors are more consoling than trust in the treating physician-trust that the physician is recommending the most appropriate treatment for that individual while minimizing bias or conflict of interest. Unfortunately, the upheaval in the medical care delivery system over the past decade has threatened many patient/physician relationships by restricting referral patterns and losing focus on what is best for patients. Financial incentives offered to physicians from hospitals and industry have further distorted these relationships. The American health care consumer has a right to question physician medical decision-making, such as who is making decisions and why many decisions are made. This distortion of the medical decision-making process has led to a decline in patient trust.
No doubt physicians have also suffered from this decline in patient trust, but they are also partly to blame. Recent government regulations such as the Sunshine Act 7 have disclosed many unhealthy relationships between physicians and those with financial stakes in the medical industry. From pharmaceutical companies to medical device manufacturers, many restrictions have been enacted to protect the patient. Collaborations between the medical industry and physicians can have huge benefits for patients, as long as the financial profits do not distort the medical decision-making process. 6 Physicians in academic centers have seen increasing scrutiny of their relationships with industry, which can influence the patient/ physician relationship. Some restrictions appear to have gone too far, making reasonable professional intellectual exchanges between physicians and industry professionals difficult at best. On the other hand, junkets to resorts are not necessary for professional discourse. A healthier environment may be available to physicians in private practice who are subject to less scrutiny and freer to pursue business relationships in an ethical manner.
Public opinion on many medical matters is often formed by personal experience but is also influenced by the mass media.
The appearance of conflict in the media is as harmful as the conflict itself with respect to patient/physician trust. Recent reports of Medicare and Medicaid fraud have not improved the image of modern medicine.
1,4 Surgeons themselves are often aware of those in their own profession who provide care to optimize their own financial benefit. This is a major problem for the rest of the medical community, who have few options to address these unprofessional practices that violate our medical oaths.
A recent example of these scandalous medical practices is the aggressive marketing and use of biologics without appropriate medical science evidence. While the excitement over cell-based therapies and regenerative medicine is understandable, it is very clear that the medical evidence-based indications for these new treatments are very few, 2 ,5 yet the marketing and rampant adoption of these treatments to injuries, conditions, and diseases without sufficient clinical evidence or validation is dishonest and experimental. This scam has further downgraded the patient/ physician relationship.
So who is to blame for this medical quagmire where many patients will be seduced by false or inaccurate claims about treatments, and some will even suffer dire consequences? No doubt, individual physicians who are utilizing these therapies for financial gain without adequate medical evidence of benefit are a problem. The marketing to patients of unproven benefits without proof of efficacy and adequate follow-up amounts to experimenting on patients without informed consent. This is ethically challenging behavior and will continue to be problematic in our society, where the Food and Drug Administration has maintained a very lax atmosphere for stem cell and biologic treatments.
Professional medical societies certainly have the structure and the responsibility to pursue, present, and disseminate valid medical evidence for new treatment options. 3 These societies sponsor educational opportunities that help translate scientific and medical research into appropriate delivery of medical care. Medical societies are the most appropriate forum for the scrutiny and dissemination of new treatment techniques and scientific developments, and society members rely on their professional organizations to be independent, authoritative facilitators in the medical science arena, providing a conflict of interest-and bias-free environment. These professional organizations can certainly help medical decision makers who are responsible for determining whether a treatment is safe and reasonable to the point that it can be recommended as good medical care.
Public confidence in the independence and objectivity of medical societies is critical to accomplishing these societies' goal of guiding the delivery of medical care. To accomplish this mission, medical societies must be capable of minimizing actual and perceived conflict of interest. Every medical society and its physician leaders must ensure that its interactions with the medical industry meet the highest ethical standards. 3 Many clinicians see patients-many times athletes-in pain who are searching for a quick fix or hope for a cure. Educating patients and helping them decide on the most efficacious treatment is our obligation. However, the marketing and recommendation of treatments with no medical evidence of their efficacy in routine clinical practice is unprofessional and not within the ethical standards of medicine.
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